ACADIA PHARMACEUTICALS INC Quarterly Entity Common Stock, Shares Outstanding from Q2 2011 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Acadia Pharmaceuticals Inc quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q2 2011 to Q3 2024.
  • Acadia Pharmaceuticals Inc Entity Common Stock, Shares Outstanding for the quarter ending October 29, 2024 was 166M shares, a 1.35% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 166M +2.21M +1.35% Oct 29, 2024 10-Q 2024-11-07
Q2 2024 166M +2.15M +1.31% Jul 31, 2024 10-Q 2024-08-07
Q1 2024 165M +2.6M +1.6% Apr 30, 2024 10-Q 2024-05-09
Q3 2023 164M +2.25M +1.39% Oct 25, 2023 10-Q 2023-11-03
Q2 2023 164M +1.89M +1.17% Jul 26, 2023 10-Q 2023-08-03
Q1 2023 163M +1.2M +0.74% Apr 26, 2023 10-Q 2023-05-08
Q3 2022 162M +1.18M +0.73% Oct 21, 2022 10-Q 2022-11-03
Q2 2022 162M +1.2M +0.75% Jul 28, 2022 10-Q 2022-08-09
Q1 2022 161M +1.25M +0.78% Apr 28, 2022 10-Q 2022-05-05
Q3 2021 161M +1.78M +1.12% Oct 25, 2021 10-Q 2021-11-09
Q2 2021 161M +2.96M +1.88% Jul 28, 2021 10-Q 2021-08-05
Q1 2021 160M +4.45M +2.86% Apr 27, 2021 10-Q 2021-05-06
Q4 2020 160M +4.71M +3.03% Feb 10, 2021 10-K 2021-02-25
Q3 2020 159M +4.95M +3.22% Oct 22, 2020 10-Q 2020-11-04
Q2 2020 158M +13.2M +9.13% Jul 22, 2020 10-Q 2020-08-06
Q1 2020 156M +11.6M +8.02% Apr 22, 2020 10-Q 2020-05-08
Q4 2019 155M +11.5M +7.96% Jan 31, 2020 10-K 2020-02-27
Q3 2019 154M +29M +23.1% Oct 23, 2019 10-Q 2019-10-31
Q2 2019 144M +19.5M +15.6% Jul 24, 2019 10-Q 2019-08-01
Q1 2019 144M +19.3M +15.5% Apr 24, 2019 10-Q 2019-05-02
Q4 2018 144M +19.2M +15.4% Jan 31, 2019 10-K 2019-02-27
Q3 2018 125M +869K +0.7% Oct 31, 2018 10-Q 2018-11-06
Q2 2018 125M +2.61M +2.13% Jul 31, 2018 10-Q 2018-08-08
Q1 2018 125M +2.78M +2.28% Apr 30, 2018 10-Q 2018-05-04
Q4 2017 125M +3.29M +2.71% Jan 31, 2018 10-K 2018-02-27
Q3 2017 124M +3.09M +2.55% Oct 31, 2017 10-Q 2017-11-07
Q2 2017 122M +8.39M +7.36% Jul 31, 2017 10-Q 2017-08-08
Q1 2017 122M +8.88M +7.85% May 3, 2017 10-Q 2017-05-09
Q4 2016 121M +8.77M +7.79% Jan 31, 2017 10-K 2017-02-28
Q3 2016 121M +20.2M +20% Oct 31, 2016 10-Q 2016-11-07
Q2 2016 114M +13.3M +13.2% Jul 29, 2016 10-Q 2016-08-04
Q1 2016 113M +12.9M +12.8% Apr 28, 2016 10-Q 2016-05-05
Q4 2015 113M +12.5M +12.4% Jan 29, 2016 10-K 2016-02-29
Q3 2015 101M +1.14M +1.14% Oct 30, 2015 10-Q 2015-11-05
Q2 2015 101M +1.28M +1.29% Jul 31, 2015 10-Q 2015-08-06
Q1 2015 100M +1.32M +1.34% Apr 30, 2015 10-Q 2015-05-07
Q4 2014 100M +8.82M +9.66% Jan 30, 2015 10-K 2015-02-26
Q3 2014 99.8M +8.9M +9.8% Oct 31, 2014 10-Q 2014-11-10
Q2 2014 99.4M +10.7M +12% Jul 31, 2014 10-Q 2014-08-05
Q1 2014 99M +19.8M +25% Apr 30, 2014 10-Q 2014-05-06
Q4 2013 91.3M Jan 31, 2014 10-K 2014-02-27
Q3 2013 90.9M +34.2M +60.5% Oct 31, 2013 10-Q 2013-11-06
Q2 2013 88.8M +35.8M +67.4% Jul 31, 2013 10-Q 2013-08-06
Q1 2013 79.2M +26.2M +49.6% Apr 29, 2013 10-Q 2013-05-07
Q3 2012 56.6M +3.82M +7.24% Oct 31, 2012 10-Q 2012-11-05
Q2 2012 53M +230K +0.44% Jul 31, 2012 10-Q 2012-08-08
Q1 2012 52.9M Apr 30, 2012 10-Q 2012-05-08
Q3 2011 52.8M Oct 31, 2011 10-Q 2011-11-09
Q2 2011 52.8M Jul 31, 2011 10-Q 2011-08-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.